Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
Tel: +008618049624045
Tel: +008615877690239
Tel: +0086-18792996027
Tel: +008618049624045
Tel: +008618291367393
Tel: +8618629260427
Tel: +008617802922472
Tel: +008618729964529
Mobile: 18049624045
Tel: +008618049624045
Fax:
URL: http://LookChem.com
Province/state: Shaan xi
City: xi'an
Street: Xi'an
MaxCard:
CAS NO.540737-29-9
98%(1-10)Kilogram98%(10-25)Kilogram98%(25-100)Kilogram
We promise our customer following items:
1.Support product customization:
We can provide OEM&ODM , Because we have a professional design team
2.Reasonable price:
We provide high quality products with competitive price in china,
3.Low moq:
No worry about the low moq, our moq is 1 gram or lower.
3.Good and efficient service,Fast Delivery
Fast respond save client's time, we promise to reply inquiry in 24 hours including holidays and send quotation sheet and other documents in 48 hours.
4.Super-good quality
We have strict quality control system .Good reputation in Market , And have the Third party test report is available
Pls contact us
If you have any further questions or need a sample,Please do not hesitate to contact us.
Xi'an Julong Bio-Tech Co., Ltd.
High Purity Best Price CAS 540737-29-9 Tofacitinib Powder
Product Name | Tofacitinib |
CAS | 540737-29-9 |
MF | C16H20N6O.C6H8O7 |
Storage temp | Store at RT |
Assay | 99% Min. |
Appearance | White Crystalline Solid |
Tofacitinib (formerly tasocitinib, CP-690550) is a drug being investigated by Pfizer for the treatment of rheumatoid arthritis (RA), psoriasis,
inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. It is an inhibitor of
the enzyme Janus kinase 3 (JAK3), which means that it interferes with the JAK-STAT signaling pathway that transmits information outside the
cell into the cell nucleus, influencing DNA transcription. Recently it has been shown in a murine model of established arthritis, tofacitinib
rapidly improved disease by inhibiting the production of inflammatory mediators and suppressing STAT1-dependent genes in joint tissue. This
efficacy in this disease model correlated with the inhibition of both JAK1 and 3 signaling pathways, suggesting that tofacitinib may exert
therapeutic benefit via pathways that are not exclusive to inhibition of JAK3.
Julong Bio-Tech Co., Ltd. is located in Xi'an City, Shaanxi Province, China. It is a biotechnology enterprise engaged in the research,
development,production and sales of animal and plant extracts, cosmetics, pharmaceutical raw materials and intermediates. The company has
complete experimental facilities. And advanced testing instruments ensure the stability of product quality from all aspects. The company has
a complete sales service system, the products are exported to countries all over the world, and have won a good international reputation with
excellent quality and excellent service.
The company has been adhering to the basic principles of "integrity, quality, service, and win-win" to serve customers, constantly strict
requirements, set goals, and implement win-win development.
By Express | By Air | By Sea |
Suitable for under 50kg Fast: 3-7 days High cost Door to door service, easy to pick up the goods |
Suitable for more than 50kg Fast: 3-7 days High cost Port to port, professional broker needed |
Suitable for more than 500kg Slow: 7-45 days Low cost Port to port, professional broker needed |